Evaluation of bronchoalveolar lavage fluid combined with the loop-mediated isothermal amplification assay in lower respiratory tract infections.

Zaiqiang Wang, Yu Zang, Yanjun Gao, Luyao Han, Hongwei Lin, Yongheng Gao, Min Chen, Yurou Liu, Qian Zhang, Enqing FuPubMed 2020

TL;DR

This study investigates the diagnostic accuracy of the Loop-Mediated Isothermal Amplification (LAMP) assay for lower respiratory tract infections (LRTIs) by comparing it to traditional bacterial culture using bronchoalveolar lavage fluid (BALF). The findings suggest that LAMP offers a higher positive detection rate and better consistency with bacterial culture when using BALF, a less contaminated sample than sputum, paving the way for its wider clinical adoption.

What Problem Does This Paper Address?

Lower respiratory tract infections (LRTIs) are a significant cause of mortality globally. Accurate and timely identification of the causative pathogens is crucial for effective treatment and to combat antibiotic misuse. While bacterial culture has been the gold standard, it's slow, prone to contamination, and can have a low positive rate. Newer methods like quantitative PCR (qPCR) are faster but expensive. The Loop-Mediated Isothermal Amplification (LAMP) assay offers a promising alternative due to its low cost, simplicity, and speed. However, its clinical adoption has been hampered by inconsistent results compared to bacterial culture. A major challenge is the contamination of sputum samples with oral microorganisms, which can lead to false negatives in culture and false positives in molecular assays, thus reducing perceived consistency. This paper aims to address this by evaluating LAMP using bronchoalveolar lavage fluid (BALF), a sample type less susceptible to oral contamination, to provide a more accurate assessment of LAMP's diagnostic performance.

Methods

The study employed a retrospective observational design, collecting 1092 bronchoalveolar lavage fluid (BALF) samples from patients suspected of having LRTIs. For each BALF sample, two parallel diagnostic approaches were used:

  • Bacterial Culture: Standard bacteriological media (blood agar, chocolate agar, blue agar) were used to culture bacteria. Dominant colonies were then identified using a VITEK2-Compact system. A threshold of ≥ 10³ colony-forming units/mL was considered indicative of a causative pathogen.
  • Loop-Mediated Isothermal Amplification (LAMP) Assay: DNA was extracted from BALF samples using a commercial kit. The LAMP assay was performed using a specific kit designed for detecting nine common respiratory bacterial pathogens. The reaction was carried out on an RTisochip™™-A analyzer. Results were interpreted as positive if the time-to-positive value was less than or equal to the positive control.

Statistical analysis included the Kappa coefficient to measure agreement between the two methods and the McNemar χ² test to compare positive rates.

Datasets

The study utilized a dataset of 1092 bronchoalveolar lavage fluid (BALF) samples collected from patients at Tang Du Hospital between January and September 2018. This dataset was used for parallel testing with both the LAMP assay and bacterial culture. No new benchmark datasets were introduced.

Key Insights and Ideas

  • BALF as a Superior Sample for LAMP Evaluation: By using BALF, the study effectively minimized the interference from oral microflora, which is a known confounder when evaluating sputum samples. This cleaner sample matrix allowed for a more direct comparison of the diagnostic capabilities of LAMP and bacterial culture.
  • LAMP's Higher Sensitivity: The study consistently found that the LAMP assay detected a significantly higher positive rate for most pathogens compared to bacterial culture. This suggests that LAMP can identify pathogens that may be missed by traditional culture methods, potentially due to low bacterial loads or the presence of non-viable but DNA-containing bacteria.
  • Improved Consistency with BALF: While previous studies using sputum showed low agreement between LAMP and culture, this study demonstrated better consistency when using BALF. This highlights the importance of sample quality in evaluating molecular diagnostic tools.
  • Implications for Antibiotic Stewardship: The higher detection rate of LAMP could lead to more targeted antibiotic use, potentially reducing the prescription of broad-spectrum antibiotics when a specific pathogen is identified quickly.

Key Results

  • Overall Positive Rate: The LAMP assay yielded an overall positive rate of 37.91% (414/1092 samples), while bacterial culture had a significantly lower positive rate of 11.81% (129/1092 samples).
  • Pathogen-Specific Detection: For most of the nine targeted pathogens, the LAMP assay showed significantly higher positive rates than bacterial culture (P < 0.05). Notable examples include Streptococcus pneumoniae (Spn), S. aureus (Sau), Methicillin-resistant S. aureus (MecA), Klebsiella pneumoniae (Kpn), and Pseudomonas aeruginosa (Pae).
  • Agreement: The study found good agreement between LAMP and bacterial culture, particularly for Pseudomonas aeruginosa (Kappa = 0.735) and Acinetobacter baumannii (Kappa = 0.687).
  • Mixed Infections: The LAMP assay identified a substantial proportion of mixed infections (51.45% of positive cases), suggesting its utility in detecting polymicrobial etiologies.
  • Predominant Pathogen: Methicillin-resistant S. aureus (MecA) was the most frequently detected pathogen by LAMP (9.43%).

Limitations and Future Work

  • Antibiotic Pre-treatment: Some patients received antibiotics before sample collection, which could reduce the positive rate of bacterial culture and potentially decrease consistency between the methods.
  • Retrospective and Single-Center Design: The study's retrospective and single-center nature limits the generalizability of the findings.
  • Absence of qPCR Comparison: The study did not include simultaneous qPCR detection, making it difficult to definitively determine if LAMP's positive results were due to true infections or non-specific gene amplification.
  • Future Work: The authors suggest that further studies are needed to validate these findings and to explore the clinical utility of LAMP in a broader context. Investigating the impact of antibiotic pre-treatment on LAMP results and comparing LAMP with qPCR would also be valuable. The study also points towards the potential for LAMP to challenge the long-standing role of bacterial culture as the gold standard for pathogen diagnosis.

Summary updated

Abstract

The clinical application of the loop-mediated isothermal amplification (LAMP) assay has been problematic because of conflicting results obtained from the LAMP assay and bacterial culture. In order to eliminate the interference of oral microorganisms and more accurately evaluate the diagnostic performance of the LAMP assay, we utilized bronchoalveolar lavage fluid (BALF) as a sample to test whether the LAMP assay and bacteria culture yielded similar results. A total of 1092 BALF samples from patients with suspected lower respiratory tract infections were collected. For each sample, parallel studies using both bacterial culture and the LAMP assay were carried out. We were the first to utilize BALF as a sample to study the consistency between the LAMP assay and bacterial culture results. The present study demonstrated that the positive rate from the LAMP assay was higher than that from bacterial culture, and the two methods had a better consistency than previously reported.
BibTeX
@inproceedings{wang2020evaluation,
  author = {Zaiqiang Wang and Yu Zang and Yanjun Gao and Luyao Han and Hongwei Lin and Yongheng Gao and Min Chen and Yurou Liu and Qian Zhang and Enqing Fu},
  title = {{Evaluation of bronchoalveolar lavage fluid combined with the loop-mediated isothermal amplification assay in lower respiratory tract infections.}},
  booktitle = {PubMed},
  year = {2020},
}
Figure